PL2181189T3 - Rekombinowany wirus zespołu rozrodczo-oddechowego świń północno-amerykańskiego typu 1 i sposoby jego stosowania - Google Patents

Rekombinowany wirus zespołu rozrodczo-oddechowego świń północno-amerykańskiego typu 1 i sposoby jego stosowania

Info

Publication number
PL2181189T3
PL2181189T3 PL08771834T PL08771834T PL2181189T3 PL 2181189 T3 PL2181189 T3 PL 2181189T3 PL 08771834 T PL08771834 T PL 08771834T PL 08771834 T PL08771834 T PL 08771834T PL 2181189 T3 PL2181189 T3 PL 2181189T3
Authority
PL
Poland
Prior art keywords
methods
american type
north american
respiratory syndrome
syndrome virus
Prior art date
Application number
PL08771834T
Other languages
English (en)
Inventor
Ying Fang
Jane Hennings
Original Assignee
South Dakota State Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South Dakota State Univ filed Critical South Dakota State Univ
Publication of PL2181189T3 publication Critical patent/PL2181189T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08771834T 2007-06-25 2008-06-24 Rekombinowany wirus zespołu rozrodczo-oddechowego świń północno-amerykańskiego typu 1 i sposoby jego stosowania PL2181189T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94608007P 2007-06-25 2007-06-25
PCT/US2008/068041 WO2009002981A1 (en) 2007-06-25 2008-06-24 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
EP08771834A EP2181189B1 (en) 2007-06-25 2008-06-24 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use

Publications (1)

Publication Number Publication Date
PL2181189T3 true PL2181189T3 (pl) 2012-11-30

Family

ID=39811835

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08771834T PL2181189T3 (pl) 2007-06-25 2008-06-24 Rekombinowany wirus zespołu rozrodczo-oddechowego świń północno-amerykańskiego typu 1 i sposoby jego stosowania

Country Status (11)

Country Link
US (1) US8182984B2 (pl)
EP (1) EP2181189B1 (pl)
JP (1) JP2010531143A (pl)
KR (1) KR20100058451A (pl)
CN (1) CN101848995A (pl)
CA (1) CA2691755A1 (pl)
DK (1) DK2181189T3 (pl)
ES (1) ES2389748T3 (pl)
MX (1) MX2010000235A (pl)
PL (1) PL2181189T3 (pl)
WO (1) WO2009002981A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009001197A1 (es) * 2009-05-15 2009-08-21 Farm En Aquacultura Veterinaria Fav S A Composicion farmaceutica veterinaria que contiene la variedad chilena del virus de la anemia infecciosa del salmon, marcadores proteicos y excipientes farmaceuticasmente aceptables; procedimiento de obtencion del virus; uso de la composicion para preparar una vacuna destinada a la prevencion del virus isa.
CN102304496B (zh) * 2010-02-05 2012-12-26 中国兽医药品监察所 高致病性猪繁殖与呼吸综合征病毒弱毒疫苗株GDr株的致弱培育
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
MX2015000711A (es) 2012-07-18 2016-03-04 South Dakota Board Of Regents Proteina de arterivirus novedosa y mecanismos de expresion.
US9457073B2 (en) * 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
CN103087996B (zh) * 2013-01-18 2014-07-16 中国农业大学 重组猪繁殖与呼吸综合征病毒及其制备方法与应用
CN103773740B (zh) * 2013-12-19 2016-08-17 广东省农业科学院动物卫生研究所 猪呼吸与繁殖综合征病毒复制缺陷性病毒疫苗株的构建及应用
EA039060B1 (ru) 2013-12-20 2021-11-29 Бёрингер Ингельхайм Ветмедика Гмбх Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс
CN105603040A (zh) * 2015-11-10 2016-05-25 环境保护部华南环境科学研究所 一种观察不同生理状态pc12细胞之间相互影响的方法
US10729756B2 (en) 2017-05-30 2020-08-04 The United States Of America, As Represented By The Secretary Of Agriculture Viable viruses with foreign tags
CN109554375A (zh) * 2018-12-13 2019-04-02 郑州大学 美洲型prrsv n蛋白抗原表位及其应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
CN114778852B (zh) * 2022-04-26 2023-09-01 中国农业大学 一种检测prrsv plp2抗体的间接elisa方法
CN116004551A (zh) * 2022-09-19 2023-04-25 中国农业科学院上海兽医研究所 一种调节ciita分子的猪繁殖与呼吸综合征病毒活疫苗的构建及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601062B2 (en) * 1991-08-26 2000-12-13 Regents Of The University Of Minnesota Sirs vaccine and diagnosis method
US6080570A (en) * 1991-08-26 2000-06-27 Boehringer Ingelheim Vetmedica, Inc. Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
MX9204885A (es) * 1991-08-26 1994-05-31 Boehringer Animal Health Inc Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos.
US5846805A (en) * 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US6982160B2 (en) * 1991-08-26 2006-01-03 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions that include SIRS virus
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
DE69426228T2 (de) * 1993-02-08 2001-03-01 Bayer Ag Verfahren zum Vermehren des das Reproduktions- und Atemwegs-Syndrom verursachenden Schweinevirus und dessen Verwendung als Impfstoff.
JP3748887B2 (ja) * 1994-08-05 2006-02-22 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Ｖｒ−２３３２ ウィルスヌクレオチド配列および使用方法
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
US7691389B2 (en) * 1998-12-22 2010-04-06 Pfizer Inc Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2290220C (en) * 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
US7132106B2 (en) * 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
CA2370372C (en) * 1999-04-22 2009-02-24 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
EP1255815B1 (en) * 2000-02-08 2006-07-19 Regents Of The University Of Minnesota Porcine reproductive and respiratory syndrome virus and methods of use
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
WO2007065151A2 (en) * 2005-12-02 2007-06-07 Iowa State University Research Foundation, Inc. Differential immunoassay for prrs vaccine antibody

Also Published As

Publication number Publication date
KR20100058451A (ko) 2010-06-03
CN101848995A (zh) 2010-09-29
CA2691755A1 (en) 2008-12-31
US20100136047A1 (en) 2010-06-03
WO2009002981A1 (en) 2008-12-31
DK2181189T3 (da) 2012-09-24
JP2010531143A (ja) 2010-09-24
US8182984B2 (en) 2012-05-22
ES2389748T3 (es) 2012-10-31
MX2010000235A (es) 2010-08-02
EP2181189B1 (en) 2012-06-20
EP2181189A1 (en) 2010-05-05

Similar Documents

Publication Publication Date Title
PL2181189T3 (pl) Rekombinowany wirus zespołu rozrodczo-oddechowego świń północno-amerykańskiego typu 1 i sposoby jego stosowania
TWI366602B (en) N protein mutants of porcine reproductive and respiratory syndrome virus
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
EP2370817A4 (en) IDENTIFICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS
HK1254832A1 (zh) 北美豬繁殖與呼吸綜合徵(prrs)病毒及其應用
EP2099825A4 (en) RECOMBINANT ANTIBODIES TO THE HEPATITIS C VIRUS AND METHOD FOR THEIR RECEIVING AND USE THEREOF
EP1960960A4 (en) Full face respiratory mask with integrated nasal interface
ZA200802501B (en) Indenoisoquinolinone analogs and methods of use thereof
IL200432A (en) Human antibodies against hepatitis C virus and their uses
EP2102237A4 (en) RECOMBINANT HUMAN FACTOR IX AND USE THEREOF
EP2328612A4 (en) VACCINE AGAINST HIGH PATHOGENIC DISEASED LATE LIVESTOCK (PRRS)
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
SI2083811T1 (sl) Postopki zdravljenja Downovega sindroma, sindroma krhkega X in avtizma
PL2061485T3 (pl) Peptydy EV576 do zastosowania w leczeniu zespołu Guillaina-Barrégo
PL2010209T3 (pl) Immunogeniczne peptydy WT-1 i sposoby ich użycia
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
PL1856534T3 (pl) Peptydy do wykrywania przeciwciała wirusa zespołu rozrodczo-oddechowego świń
EP2106440A4 (en) NON-SIMILAR CELLS FOR THE GROWTH OF THE PRRS VIRUS
IL195272A0 (en) Methods and compositions for the treatment of viral infections
EP2010645A4 (en) RECOMBINANT LACTOBACILLUS AND USE THEREOF
GB2443336B (en) Spiruchostatin analogues and their medicinal use
EP1868636A4 (en) USE OF RECOMBINANT SUPERCOMPOSE INTERFERONS
ZA200808950B (en) Garment for use with an absorbent structure and its methods of manufacture
ZA201004994B (en) Recombinant rift valley fever (rvf)viruses and methods of use
GB0615635D0 (en) Immunogenic proteins and uses thereof